First Time Loading...

Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 98 GBX -1.51% Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

The Relative Value of one DXRX stock under the Base Case scenario is 168.13 GBX. Compared to the current market price of 98 GBX, Diaceutics PLC is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DXRX Relative Value
Base Case
168.13 GBX
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.8
P/S
P/S
Price to Sales
3.8
vs History
52
vs Industry
49
Median 3Y
4.6
Median 5Y
4
Industry
3.9
Forward
3.4
More Details
13 797.2
P/E
P/E
Price to Earnings
13 797.2
vs History
7
vs Industry
100
Median 3Y
399.6
Median 5Y
124.3
Industry
31.1
Forward
-55.9
More Details
32.7
P/OCF
P/OCF
Price to OCF
32.7
vs History
36
vs Industry
17
Median 3Y
34.2
Median 5Y
28.4
Industry
23.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
1
Median 3Y
-24.8
Median 5Y
-28.5
Industry
27.4
More Details
2
P/B
P/B
Price to Book Value
2
vs History
68
vs Industry
54
Median 3Y
2.1
Median 5Y
2.3
Industry
2.5
More Details
3
EV/S
EV/S
Enterprise Value to Sales
3
vs History
49
vs Industry
54
Median 3Y
3.7
Median 5Y
3.1
Industry
3.8
Forward
2.7
More Details
3.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.2
vs History
52
vs Industry
72
Median 3Y
4.3
Median 5Y
3.5
Industry
7.9
More Details
21.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.5
vs History
41
vs Industry
22
Median 3Y
23.4
Median 5Y
20.2
Industry
17.2
Forward
29.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
3
Median 3Y
-55.7
Median 5Y
-132.3
Industry
22.7
Forward
-56.1
More Details
26.1
EV/OCF
EV/OCF
Enterprise Value to OCF
26.1
vs History
36
vs Industry
25
Median 3Y
27.6
Median 5Y
21.8
Industry
21.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
2
Median 3Y
-14.9
Median 5Y
-21.4
Industry
27.9
More Details
2.4
EV/IC
EV/IC
Enterprise Value to IC
2.4
vs History
69
vs Industry
44
Median 3Y
2.6
Median 5Y
3
Industry
2.4
More Details

Multiples Across Competitors

DXRX Competitors Multiples
Diaceutics PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Diaceutics PLC
LSE:DXRX
82.8m GBP 3.8 13 797.2 21.5 -125.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.3B USD 5.2 36.9 22.8 33.4
US
Danaher Corp
NYSE:DHR
184B USD 4.2 22.8 16.6 20.4
CH
Lonza Group AG
SIX:LONN
37.5B CHF 5.6 57.3 19.7 28.9
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD 2.7 29.9 16.3 25.2
US
Agilent Technologies Inc
NYSE:A
40.9B USD 6.1 33.1 26.4 31.8
KR
Samsung Biologics Co Ltd
KRX:207940
54.9T KRW 14.9 64 33.7 48.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.2 23.9 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.6B USD 9.1 46.9 32.5 39.5
IE
ICON PLC
NASDAQ:ICLR
25.6B USD 3.1 37.4 16.9 26
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.1 75.4 32.4 53.2

See Also

Summary
DXRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
DXRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DXRX stock valuation using valuation multiples.
Wall Street Estimates
DXRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DXRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.